Despite the comprehensive applications in bioimaging, biosensing, drug/gene delivery, and
tumor therapy of manganese oxide nanomaterials (MONs including MnO2, MnO, Mn2O3 …

There is urgency for the development of nanomaterials that can meet emerging biomedical
needs. Magnetic nanoparticles (MNPs) offer high magnetic moments and surface‐area‐to …

In vivo imaging, which enables us to peer deeply within living subjects, is producing
tremendous opportunities both for clinical diagnostics and as a research tool. Contrast …

Magnetic nanoparticles (MNPs) have been extensively explored as magnetic resonance
imaging (MRI) contrast agents. With the increasing complexity in the structure of modern …

Ferroptosis, an iron-based cell-death pathway, has recently attracted great attention owing
to its effectiveness in killing cancer cells. Previous investigations focused on the …

Drug molecules transformed into nanoparticles or endowed with nanostructures with or
without the aid of carrier materials are referred to as “nanomedicines” and can overcome …

Magnetic resonance imaging (MRI) is a highly valuable non-invasive imaging tool owing to
its exquisite soft tissue contrast, high spatial resolution, lack of ionizing radiation, and wide …

In the past two decades, the synthetic development of magnetic nanoparticles (NPs) has
been intensively explored for both fundamental scientific research and technological …

In 2004, the US Food and Drug Administration (FDA) released an important report entitled
“Innovation/Stagnation: Challenge and Opportunity on the Critical Path to New Medical …

Cancer, one of major threats to the human health, possesses intricate structure and
constituents distinctive from normal organs and tissues. It has been well recognized that the …